Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	1,844	1,392	2,413
Short-Term Investments	1,030	1,050	580
Cash & Short-Term Investments	2,874	2,442	2,993
Cash Growth	11.76%	-18.41%	-
Accounts Receivable	836.3	830.75	716.77
Inventory	437.5	416.96	480.45
Other Current Assets	435	476.44	438.95
Total Current Assets	4,583	4,166	4,629
Net Property, Plant & Equipment	258.9	258.74	227
Other Intangible Assets	4,204	4,430	4,756
Goodwill	1,805	1,829	1,716
Other Long-Term Assets	1,009	975.71	684.22
Total Assets	11,860	11,659	12,012
Accounts Payable	100	122.06	77.87
Accrued Expenses	1,022	1,034	910.95
Current Portion of Long-Term Debt	1,031	1,030	31
Other Current Liabilities	93.7	56.39	18.76
Total Current Liabilities	2,247	2,243	1,039
Long-Term Debt	4,324	4,328	6,078
Long-Term Leases	47.3	50.89	38.94
Other Long-Term Liabilities	709.2	718.99	763.35
Total Long-Term Liabilities	5,081	5,098	6,880
Total Liabilities	7,327	7,341	7,919
Common Stock	0.6	0.53	0.53
Additional Paid-in Capital	4,244	4,240	3,914
Accumulated Other Comprehensive Income	-651	-568.6	-947.67
Retained Earnings	939.2	646.18	1,127
Shareholders' Equity	4,532	4,319	4,094
Total Liabilities & Equity	11,860	11,659	12,012
Total Debt	5,402	5,409	6,148
Net Cash (Debt)	-2,528	-2,967	-3,155
Net Cash Per Share	-40.07	-48.66	-47.79
Book Value	4,532	4,319	4,094
Book Value Per Share	71.85	70.82	62.02
Tangible Book Value	-1,477	-1,940	-2,378
Tangible Book Value Per Share	-23.41	-31.82	-36.03

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q